Name | Distance Points | Day Points | Encourager Points | Total Points |
---|---|---|---|---|
Total Score | 302 | 120 | 0 | 422 |
Ross Borthwick | 119 | 50 | 0 | 169 |
Alastair Nixon | 71 | 20 | 0 | 91 |
Michelle Fry | 47 | 20 | 0 | 67 |
Tom Keith Welsh | 36 | 20 | 0 | 56 |
Alison Vessey | 29 | 10 | 0 | 39 |
Name | Staff Count | Distance Points | Day Points | Encourager Points | Total Points |
---|---|---|---|---|---|
AIML | 35 | 0 | 0 | 0 | 0 |
CBS FInance | 100 | 0 | 0 | 0 | 0 |
CBS IT R&D | 100 | 0 | 0 | 0 | 0 |
Communications & Government Affairs | 150 | 0 | 0 | 0 | 0 |
Consumer Healthcare | 6 | 0 | 0 | 0 | 0 |
G-ERP | 100 | 0 | 0 | 0 | 0 |
Name | Department | Last login | ||
---|---|---|---|---|
Shraddha Sharma | WREF | over 2 years | Encourage | |
Julie Anderson | R&D | almost 3 years | Encourage | |
Janet Flemming | 3 years | Encourage | ||
Sue Blaikie | UK Clinical Operations | over 3 years | Encourage | |
Darshana Patel | over 3 years | Encourage | ||
Lionel Tan | R&D | over 3 years | Encourage | |
Conor Hanna | R&D | over 3 years | Encourage | |
Toni Maslen | UK & Ireland Medical | over 3 years | Encourage | |
Mark Davies | over 3 years | Encourage | ||
Prasanth Kumar | R&D | almost 4 years | Encourage |
Name | staff | Riders | Distance (miles) | Trips | Transport Trips |
---|---|---|---|---|---|
WREF | 50 | 5 | 9859 | 743 | 188 |
PCPS | 100 | 9 | 14096 | 462 | 72 |
Communications & Government Affairs | 150 | 1 | 399 | 44 | 4 |
G-ERP | 100 | 0 | 0 | 0 | 0 |
SMAS GMS | 3 | 1 | 16 | 2 | 2 |
R&D | 1000 | 23 | 88283 | 4692 | 745 |
CBS FInance | 100 | 4 | 264 | 20 | 14 |
AIML | 35 | 0 | 0 | 0 | 0 |
UK Clinical Operations | 120 | 3 | 4647 | 351 | 45 |
UK & Ireland Medical | 85 | 0 | 0 | 0 | 0 |
UK & Ireland Medical | 85 | 0 | 0 | 0 | 0 |
Strategy & Global Logistics | 15 | 0 | 0 | 0 | 0 |
Pharma Tech UK & Ireland | 6 | 1 | 10585 | 390 | 92 |
GSF IT | 100 | 0 | 0 | 0 | 0 |
Consumer Healthcare | 6 | 1 | 25 | 4 | 4 |
UK Pharma Respiratory | 30 | 3 | 16474 | 763 | 66 |
UK Pharma IG | 60 | 1 | 108 | 5 | 5 |
HR | 100 | 0 | 0 | 0 | 0 |
GLobal Respiratory Franchise | 80 | 0 | 0 | 0 | 0 |
CBS IT R&D | 100 | 1 | 37 | 3 | 0 |